NVO Competitors & Alternatives
Compare Novo Nordisk A/S with similar stocks in the same industry
Drug Manufacturers - General
NVO
Main Stock$50.43
Tradestie Score
58
Market Cap
$262.92B
P/E Ratio
11.7
Revenue Growth
0.2%
Analyst Upside
-5.6%
Top Competitors
20 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
|
$425.36
|
$315.45B | 32.1 | 59 | Compare |
|
AZN
AstraZeneca PLC
|
$195.15
|
$261.56B | 29.2 | 62 | Compare |
|
NVS
Novartis AG
|
$159.90
|
$254.99B | 22.1 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$129.56
|
$225.13B | 35.3 | 62 | Compare |
|
AMGN
Amgen Inc
|
$374.15
|
$160.70B | 25.1 | 69 | Compare |
|
PFE
Pfizer Inc.
|
$24.32
|
$154.70B | 18.2 | 60 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.27
|
$137.92B | 17.2 | 67 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$43.16
|
$121.27B | 18.4 | 56 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$58.13
|
$96.54B | 15.8 | 63 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$53.66
|
$91.59B | 13.7 | 66 | Compare |
More NVO Analysis
Data updated: Jul 04, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
20 stocks in this industry